Newly Approved Drug Improves Sleep Onset in Insomnia

Newly Accepted Drug Improves Sleep Onset in Insomnia

The newly approved insomnia drug daridorexant (Quviviq) improves sleep onset in adults, new phase 3 data suggest.   In the first of two studies, a 50-mg dose of daridorexant was associated with a reduction in latency to persistent sleep (LPS) of 11.7 minutes at month 3 vs placebo. The drug was also associated with improved…